Transcend Therapeutics
Drug Discovery
3 open rolesDrug DiscoveryNew York, United States14 employees$50M raisedEst. 2021
FJ Labs
Alpha Wave Global
Integrated Investment Partners
AlleyCorp
Emerald Development Managers
Global Founders Capital
About Transcend Therapeutics
- Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases.
- They aim to develop new drugs for the millions of people for whom current psychiatric medicines have not worked.
Transcend Therapeutics is listed on Rocketlist with 3 active roles. The company is categorized as Drug Discovery in BioTech. Transcend Therapeutics is at Series A stage, with a B2B business model, headquartered in New York, United States. Transcend Therapeutics was founded in 2021 and has 14 employees. Transcend Therapeutics has raised $50M. Active roles are refreshed daily from public hiring sources.